General Information of the Compound
| Compound ID |
CP0903995
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-Nomega-(8-Guanidino-3,6-dioxaoctyl)aminocarbonyl-Nadiphenylacetyl-(4-hydroxy benzyl)argininamidebis(hydrotrifluoroacetate)
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C37H48F3N9O8
|
||||||||||||||||||
| Molecular Weight |
803.84
|
||||||||||||||||||
| Canonical SMILES |
N=C(N)NCCOCCOCCNC(=O)/N=C(/N)NCCC[C@@H](NC(=O)C(c1ccccc1)c1ccccc1)C(=O)NCc1ccc(O)cc1.O=C(O)C(F)(F)F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H47N9O6.C2HF3O2/c36-33(37)39-18-20-49-22-23-50-21-19-41-35(48)44-34(38)40-17-7-12-29(31(46)42-24-25-13-15-28(45)16-14-25)43-32(47)30(26-8-3-1-4-9-26)27-10-5-2-6-11-27;3-2(4,5)1(6)7/h1-6,8-11,13-16,29-30,45H,7,12,17-24H2,(H,42,46)(H,43,47)(H4,36,37,39)(H4,38,40,41,44,48);(H,6,7)/t29-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LYELQEMRAKINTH-XXIQNXCHSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02259, Neuropeptide Y receptor type 1
Protein ID: PT01909, Neuropeptide Y receptor type 4
Protein ID: PT01795, Neuropeptide Y receptor type 5